The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
Shira Banki, 16, died on Sunday of stab wounds sustained when an ultra-Orthodox Jew attacked a Gay Pride parade in Jerusalem.
HSBC has reported a 10% rise in profits for the first half of the year - boosted by bumper profits in Hong Kong.
Barnado's has received £3 million to tackle child sex abuse in Rotherham, nearly a year after the Jay Report was released.